Navigation Links
Annual FIT Testing Detects Colorectal Cancer Two Years Earlier Than Colonoscopy Alone, Study of High-Risk Population Finds
Date:5/20/2008

mers, payers, suppliers and strategic partners and other factors described in the Quest Diagnostics Incorporated 2007 Form 10-K and subsequent SEC filings.

1 American Cancer Society - Cancer Facts & Figures 2008.

2 CDC, 2001 Behavioral Risk Factor Surveillance System

3 http://www.cdc.gov/cancer/colorectal/statistics/screening_rates.htm

4 American Cancer Society Guidelines on Screening and Surveillance for the

Early Detection of Colorectal Adenomas and Cancer in People at Increased Risk or at High Risk. http://www.cancer.org/docroot/CRI/content/CRI_2_4_3x_Can_Colon_and_rectum_c anc er_be_found_early.asp (Due to the length of this URL, please copy and paste into your browser)

5 American Cancer Society - Cancer Facts & Figures 2008.

6 CDC, 2001 Behavioral Risk Factor Surveillance System

7 http://www.cdc.gov/cancer/colorectal/statistics/screening_rates.htm


'/>"/>
SOURCE Quest Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Top Academic Medical Centers, Research Institutions, and Partners Gather, Share Experiences and Success Stories at Velos eResearch Annual Meeting
2. New Data Highlighting Possible Impact of ESA Reimbursement Policies on Patient Care, Nations Blood Supply, to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
3. Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO)
4. Eisais Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
5. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
6. BiPar Sciences Announces Clinical Data Presentations on Lead PARP Inhibitor, BSI-201, at 40th American Society of Clinical Oncology Annual Meeting
7. Poniard to Present Clinical Data From Picoplatin Trials in Multiple Tumor Types at American Society of Clinical Oncology 2008 Annual Meeting
8. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
9. Schering-Plough Highlights PEGINTRON(TM) and Boceprevir Hepatitis C Data Presentations at Digestive Disease Week (DDW) Annual Meeting
10. Kosan Announces Data Presentations at ASCO 2008 Annual Meeting
11. Overview of Asenapine Data from Olympia Trial Program Presented at American Psychiatric Association Annual Meeting

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...swire-FirstCall/--EchoTherapeutics,Inc.(OTCBulleti...ony(TM)tCGMSystemasanon-invasive,wireless,transder...elude(TM)SkinPrepSystemfortransdermaldrugdelivery,...ChiefExecutiveOfficer,willpresentatthe13thAnnualBi...edbytheNewYorkSocietyofSecuritiesAnalysts,at2:05on...
(Date:11/24/2009)...e/--MAQUETCardiovascularLLC,aleadingproviderofcard...edaguaranteedtwo-yearcontractwithNovation,oneofthe...esolesourceproviderofsurgicaldevicesforbeatinghear...,whichrunsthroughOctober31,2012,MAQUETCardiovascul...nddisposablesuppliestothemembersofVHAInc.andUniver...
(Date:11/24/2009)...wswire-FirstCall/--IsisPharmaceuticals,Inc.(Nasdaq...ouncedthatmanagementwillpresentacompanyoverviewatP...ay,December1,2009,at10:30a.m.ETatTheNewYorkPalaceH...beavailableonthe"Investors&Media"sectionoftheC...esentationwillbeavailableontheIsisWebsitewithin48h...
Breaking Medicine Technology:Echo Therapeutics to Present at the New York Society of Security Analysts' 13th Annual Biotech and Specialty Pharmaceuticals Conference 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Safe Ozone Levels May Not Be for Some 52829 1Safe Ozone Levels May Not Be for Some 52829 2Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 1Bioterrorism and disaster preparedness explored in special issue of Medical Decision Making 9378 2Millennium Pharmaceuticals Inc Lymphoma Research Foundation funds lymphoma research 52823 1Millennium Pharmaceuticals Inc Lymphoma Research Foundation funds lymphoma research 52823 2
...ion pyridopyrazine-urea derivative compound series... be valuable for,cancer treatment, QUEBEC, April 1...Inc. , a global, pure play biopharmaceutical compa...y presented an abstract,outlining first in vitro d...lectivity for PI3K inhibition, at the American,Ass...
...ay Provide Cancer Patients With Improved Potential...16, 2007 /PRNewswire/ -- Insert,Therapeutics, Inc....h Corporation announced today its novel delivery s...oster presentation at,the 2007 American Associatio...rticular, this poster includes new research findin...
Other Medicine Technology:AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 2AEterna Zentaris Discloses First In Vitro Data for its PI3K,Inhibitors at the AACR Annual Meeting in Los Angeles 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 2Poster on Cyclosert Drug Delivery Presented at AACR Meeting 3Poster on Cyclosert Drug Delivery Presented at AACR Meeting 4
(Date:11/24/2009)....24/PRNewswire/--Whiletheholidayseasonoftenbringsf...yearcanbedifficultforthosegrievingthedeathofaloved...andfamilies.Theholidayseasoncanbringadditionalchal...ngPlace,ACenterforGrievingChildren,AdolescentsandT...dditiontohavingavarietyofprintandonlineresourcesav...
(Date:11/24/2009)....,Nov.24/PRNewswire-FirstCall/--HealthSouthCorpora...heBankofAmericaMerrillLynch2009CreditConferenceinN...residentandTreasurerEdFaywillbespeakingonThursday,...stliveandwillbeavailableat http://investor.healths...HealthSouth ,, HealthSouthisthenation,slargest...
(Date:11/24/2009)...s didn,t differ greatly between high- and low-volu.... 24 (HealthDay News) -- Do hospitals that conduct...st results for patients? Maybe not. , Prior res...when it comes to artery-opening procedures, but a ...- and high-volume hospitals performing more or les...
(Date:11/24/2009)...a,Nov.24/PRNewswire-FirstCall/-HardtoTreatDiseases...gsubsidiarySlavicaBioChem,isprovidingthisbriefupda...inuesduediligencewiththeEUstemcellcompanyandmerger...oraboutOct29,2009whichthecompanymade. http://www.p...News . ,, HTDSandSlavicaBiochemarealsodiscussin...
(Date:11/24/2009)...24/PRNewswire/--Metastorm,aleadingproviderofBusine...PA),andEnterpriseArchitecture(EA)softwareforaligni...merisourceBergenCorporation,oneoftheworld,slargest...rdforNorthAmericainthe2009GlobalAwardsforExcellenc...implementationofMetastorm,sBPMsoftware.Theawardrec...
Breaking Medicine News(10 mins):Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 2Health News:Hard To Treat Diseases (HTDS) Exploration Of A 25 Billion Dollar Industry Regenerative Medicine and Stem Cell Bank Targeted Merger 3Health News:Metastorm Customer Wins Global Excellence in BPM & Workflow Award 2
...arch 5 AmericInn(R) International, LLC officially...,s new sleep advocacy and awareness campaign, with.... The new Web portal is designed to educate consum...ter America" Web site centralizes unique sleep-rel...
... 3, 2009) - How messages sent within stem cells th... the cells to specialize and become blood cells in...McMaster Stem Cell and Cancer Research Institute. ...way, known as the noncanonical Wnt, in inducing bl...
...lternative Reproductive Resources (ARR) today ann...economic realities given the investment required f... Alternatives ," it offers incentive pricing to in...ome egg donors," said Robin von Halle, president o...
...cabbage block protein in disease spread, study say...- A drug based on compounds extracted from crucife... offer a potent and safe treatment against melanom...production and blocked the signaling network of a ...
... and Asia to Realize New Executive Leadership , ,...okyo Stock Exchange), a leading medical diagnosti...ion systems developer, today announced executive l... Sysmex Corporate after a six-year tenure in the U...
...clinical trial involving more than 3,000 women in ...first time the promise of a vaginal microbicide ge... to findings presented at the Conference on Retrov...30% effective. While the results are encouraging, ...
Other Medicine News:Health News:AmericInn Hotels Kicks-Off 'Sleep Better America' With Launch of New Web Site to Educate Consumers About Insomnia and Sleep-Related Issues 2Health News:Drugs From Vegetables May Target Melanoma Tumors 2Health News:Sysmex Corporation Announces Organizational Changes 2Health News:Clinical trial finds microbicide promising as HIV prevention method for women 2
Kerrison style punch
Aaron 2250 Electrosurgery Generator
Sabre 2400 Electrosurgery Generator, 240V, 50Hz
ExcaliburPlus PC Electrosurgery Generator, 100V, 50Hz/60Hz
Medicine Products: